Cornerstone Advisors (Washington)’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
CS
LP
FCM
Cornerstone Advisors (Washington)'s AGN Position: Q3 2019 in Review
Cornerstone Advisors (Washington) sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 280 shares — an estimated $47K sold.
Cornerstone Advisors (Washington) first reported a position in AGN in Q4 2013 and held it in 23 quarters. The position peaked at $93K in Q1 2016. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.
- Cornerstone Advisors (Washington) reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
- Cornerstone Advisors (Washington) sold 280 Allergan plc shares in Q3 2019, an estimated $47K.
- Cornerstone Advisors (Washington) first reported a position in Allergan plc in Q4 2013 and held it in 23 quarters.
- Cornerstone Advisors (Washington)'s Allergan plc position peaked at $93K in Q1 2016.
- 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.
Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.